Raleigh, NC, United States of America

Dannie H King

This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dannie H King. Retrieved from https://idiyas.com/inventor/dannie-h-king-anokj40b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dannie H. King

Introduction

Dannie H. King is a notable inventor based in Raleigh, NC, who has made significant contributions to the field of medicine. His work primarily focuses on the treatment of idiopathic thrombocytopaenic purpura, a condition that affects blood platelet levels.

Latest Patents

Dannie H. King holds a patent for a method of treating idiopathic thrombocytopaenia purpura using 2',3'-dideoxy-3'-azidonucleosides. This includes the specific application of 3'-azido-3'-deoxythymidine, which has shown promise in addressing this medical condition.

Career Highlights

King is associated with Burroughs Wellcome Co., a company known for its innovative pharmaceutical developments. His work there has contributed to advancements in treatments for various health issues.

Collaborations

Throughout his career, Dannie has collaborated with notable colleagues, including Leone E. Kirk, III, and Richard H. Clemons. These partnerships have fostered a collaborative environment that encourages innovation and research.

Conclusion

Dannie H. King's contributions to medical science, particularly in the treatment of idiopathic thrombocytopaenic purpura, highlight his role as an influential inventor. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…